Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

[Rapid progression of hepatocellular carcinoma after surgery: apropos of a case and review of the literature].

Vergara Gómez M, Miquel Planas M, Gil Prades M, Dalmau Obrador B, Casas Rodrigo M, Sanchez Delgado J, Bella MR, Puig Domingo J.

Gastroenterol Hepatol. 2010 Oct;33(8):569-73. doi: 10.1016/j.gastrohep.2010.03.008. Epub 2010 Jun 2. Review. Spanish.

PMID:
20627456
2.

Case records of the Massachusetts General Hospital. Case 23-2005. A 57-year-old man with a mass in the liver.

Tanabe KK, Blaszkowsky LS, Chung RT, Blake MA, Lauwers GY.

N Engl J Med. 2005 Jul 28;353(4):401-10. No abstract available.

PMID:
16049213
3.

Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma.

Kilickap S, Arslan C, Senel S, Ataseven H.

J Clin Oncol. 2010 Feb 20;28(6):e99; author reply e100. doi: 10.1200/JCO.2009.26.7070. Epub 2010 Jan 19. No abstract available.

PMID:
20085931
4.
5.

Early recurrence of hepatocellular carcinoma after living donor liver transplantation.

Ohkubo T, Sugawara Y, Imamura H, Kaneko J, Matsui Y, Makuuchi M.

Hepatogastroenterology. 2004 Jan-Feb;51(55):237-8.

PMID:
15011872
6.

Decompensated hepatitis B virus-related cirrhosis successfully treated with lamivudine allowing surgery for hepatocellular carcinoma.

Nakanishi S, Michitaka K, Miyake T, Hidaka S, Yoshino I, Konishi I, Iuchi H, Horiike N, Onji M.

Intern Med. 2003 May;42(5):416-20.

7.

[Right hepatectomy in a patient with hepatocellular carcinoma after induction of hepatic parenchymal atrophy through subsequent portal and hepatic vein embolizations].

Hwang S.

Korean J Gastroenterol. 2011 Sep 25;58(3):162-5. doi: 10.4166/kjg.2011.58.3.162. Korean. No abstract available.

8.

Can antiviral therapy for chronic hepatitis B enhance the progression to hepatocellular carcinoma?

Warner N, Locarnini S.

Antivir Ther. 2009;14(2):139-42. No abstract available.

PMID:
19430088
9.

Can tertiary prevention of hepatocellular carcinoma be achieved by nucleos(t)ide analogs therapy of hepatitis B?

Chien RN.

J Gastroenterol Hepatol. 2011 Dec;26(12):1699-701. doi: 10.1111/j.1440-1746.2011.06931.x. No abstract available.

PMID:
22097937
10.

Treatment of hepatocellular carcinoma.

Hassoun Z, Gores GJ.

Clin Gastroenterol Hepatol. 2003 Jan;1(1):10-8. No abstract available.

PMID:
15017512
11.

Use of intra-arterial carbon-dioxide-enhanced ultrasonography for guidance of radiofrequency ablation and transcatheter arterial chemoembolization in hepatocellular carcinoma.

Ohmoto K, Yoshioka N, Tomiyama Y, Shibata N, Kawase T, Yoshida K, Kuboki M, Yamamoto S.

Cardiovasc Intervent Radiol. 2006 Nov-Dec;29(6):1111-3.

PMID:
16933161
12.

A patient with a large hepatocellular carcinoma alive 13 years after repeated transcatheter arterial chemoembolization and hepatectomy.

Asahara T, Dohi K, Nakahara H, Katayama K, Itamoto T, Sugino K, Ono E, Ito K, Azuma K, Shimamoto F.

Hiroshima J Med Sci. 1999 Mar;48(1):41-4.

PMID:
10213963
13.

Chemoembolization for hepatocellular carcinoma in cirrhotic patients: assessment of efficacy on total hepatectomy specimens.

Duvoux C, Cherqui D, Van Nhieu JT, Vavasseur D, Zafrani ES, Mathieu D, Fagniez PL, Dhumeaux D.

Transplant Proc. 1994 Dec;26(6):3572-3. No abstract available.

PMID:
7527981
14.

Management of hepatocellular carcinoma in homozygous β-thalassemia cirrhotic patients.

Gomatos IP, Alexakis N, Koskinas J, Smparounis SA, Katsaragakis S, Konstadoulakis MM, Zografos GC.

Am Surg. 2013 Jan;79(1):111-3. No abstract available.

PMID:
23317624
15.

Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma.

Liaw YF.

Semin Liver Dis. 2005;25 Suppl 1:40-7. Review.

PMID:
16103980
16.

[A resected case of fibrolamellar hepatocellular carcinoma with chronic hepatitis (type B)].

Ishikawa T, Kamimura H, Tsuchiya A, Watanabe K, Seki K, Ohta H, Yoshida T, Musya N, Tsubono T, Sakai Y, Takeda K, Ishihara N, Kamimura T.

Nihon Shokakibyo Gakkai Zasshi. 2007 Jul;104(7):1076-81.

PMID:
17611385
17.

Hepatocellular carcinoma and other liver lesions.

Salgia R, Singal AG.

Med Clin North Am. 2014 Jan;98(1):103-18. doi: 10.1016/j.mcna.2013.09.003. Epub 2013 Oct 18. Review.

PMID:
24266917
18.

[Prognostic factors and outcome in patients with intrahepatic recurrence after hepatectomy for hepatocellular carcinoma].

Yang LT, Cheng XD, Du YA, Wang XB, Zhang YL, Guo JM.

Zhonghua Zhong Liu Za Zhi. 2009 Aug;31(8):612-6. Chinese.

PMID:
20021950
19.

Prevention of hepatocellular carcinoma in hepatitis B virus infection.

Lim SG, Mohammed R, Yuen MF, Kao JH.

J Gastroenterol Hepatol. 2009 Aug;24(8):1352-7. doi: 10.1111/j.1440-1746.2009.05985.x. Review.

PMID:
19702903
20.

Supplemental Content

Support Center